Text Size

Improvement of Accommodation With Anti-Oxidant Supplementation in Visual Display Terminal Users

This study has been completed.
Sponsor:
Information provided by:
Ryogoku Eye Clinic
ClinicalTrials.gov Identifier:
NCT00877201
First received: April 6, 2009
Last updated: April 7, 2009
Last verified: April 2009
History of Changes
  Purpose

The purpose of this study is to determine the antioxidant supplementation effect on accommodation among visual display terminal (VDT) users.


Condition Intervention
Ocular Accommodation
 Drug: CDR2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Supportive Care

Resource links provided by NLM:

MedlinePlus related topics: Antioxidants
U.S. FDA Resources

Further study details as provided by Ryogoku Eye Clinic:

Primary Outcome Measures:
  • accommodation changes

Study Start Date: March 2007
  Eligibility

Ages Eligible for Study:   40 Years to 49 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • best corrected visual acuity is over 20/20

Exclusion Criteria:

  • receiving any medication or supplement that would alter the accommodation status within a week from the commencement of this study
  • using multifocal spectacles or contact lenses
  • pregnant or lactating mothers
  • subjects with a history of drug allergy
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00877201

Locations
Japan
Iidabashi Eye Clinic
Tokyo, Japan, 102-0072
Sponsors and Collaborators
Ryogoku Eye Clinic
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00877201     History of Changes
Other Study ID Numbers: Ryogoku6886
Study First Received: April 6, 2009
Last Updated: April 7, 2009
Health Authority: Japan: Institutional Review Board

Keywords provided by Ryogoku Eye Clinic:
Accommodation
visual display terminal (VDT)
antioxidant

Additional relevant MeSH terms:
Antioxidants
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protective Agents
Physiological Effects of Drugs

ClinicalTrials.gov processed this record on May 16, 2013